Mounting evidence links ERCC6L2 to a distinct inherited bone marrow failure syndrome (IBMFS) that includes developmental delay, microcephaly, and predisposition to cancer.24 Here, ERCC6L2 is linked to inherited bone marrow failure syndrome.